Related Experiment Video
Updated: May 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The Predictive Value of the CHA2DS2-VASc Score in the Development of Contrast-Induced Nephropathy after Endovascular
Ali Evsen1, Adem Aktan2, Raif Kılıç2
1Dağkapı State Hospital, Department of Cardiology, Diyarbakır, Turkey.
Insights
The CHA2DS2-VASc score predicts contrast-induced nephropathy (CIN) in peripheral artery disease (PAD) patients undergoing endovascular procedures. A higher score indicates increased risk for developing CIN, aiding in risk stratification.
Area of Science:
- Cardiology
- Nephrology
- Vascular Surgery
Background:
- Contrast-induced nephropathy (CIN) is a significant complication following endovascular interventions for peripheral artery disease (PAD).
- CIN is associated with adverse outcomes including renal dysfunction, prolonged hospitalization, and increased mortality.
- The CHA2DS2-VASc score, typically used for cardioembolic risk, shares risk factors with CIN.
Purpose of the Study:
- To evaluate the predictive capability of the CHA2DS2-VASc score for CIN development in PAD patients.
- To determine if the CHA2DS2-VASc score can serve as a risk stratification tool for CIN.
Main Methods:
- A retrospective analysis of 754 PAD patients undergoing endovascular procedures was conducted.
- Patients were stratified by CHA2DS2-VASc score (low <3, high ≥3) and monitored for CIN development.
- Univariate and multivariate regression analyses identified independent predictors of CIN.
Main Results:
- 178 (23.6%) patients developed CIN, with 84.8% in the high CHA2DS2-VASc score group (P < 0.001).
- The CHA2DS2-VASc score was significantly higher in CIN-positive patients (P < 0.001).
- Independent predictors of CIN included CHA2DS2-VASc score (OR: 1.574), baseline creatinine, and hemoglobin.
Conclusions:
- The CHA2DS2-VASc score is an independent predictor of CIN in PAD patients undergoing endovascular intervention.
- This score can aid clinicians in identifying high-risk patients for CIN.
Background:
Contrast-induced nephropathy (CIN) is a frequent complication of endovascular interventions for peripheral artery disease (PAD). It is linked to renal dysfunction, extended hospital stays, increased cardiovascular events, and higher mortality rates. The CHA2DS2-VASc score, widely utilized for assessing cardioembolic risk and guiding anticoagulation therapy in nonvalvular atrial fibrillation, encompasses risk factors that overlap with those of CIN. This study investigates whether the CHA2DS2-VASc score can predict CIN in PAD patients undergoing endovascular interventions.
Methods:
The study included 754 consecutive PAD patients who underwent endovascular procedures at 2 centers. Each patient's CHA2DS2-VASc score was calculated and categorized into low (<3) and high (≥3) groups. Patients were retrospectively monitored for CIN development and divided into CIN-positive (CIN+) and CIN-negative (CIN-) groups. Univariate and multivariate regression analyses were performed to identify independent predictors of CIN, and a significance level of P < 0.05 was used for all statistical analyses.
Results:
Of the 754 patients, 178 (23.6%) developed CIN, with 151 (84.8%) occurring in the high CHA2DS2-VASc score group (P < 0.001). The CHA2DS2-VASc score was significantly higher in the CIN(+) group compared to the CIN(-) group (P < 0.001). Regression analysis identified the CHA2DS2-VASc score (odds ratio [OR]: 1.574, 95% confidence interval [CI]: 1.298-1.907, P < 0.001), baseline creatinine (OR: 2.296, 95% CI: 1.580-3.335, P < 0.001), and hemoglobin (OR: 0.915, 95% CI: 0.844-0.992, P < 0.001) as independent risk factors. A CHA2DS2-VASc score cutoff of 2.5 predicted CIN with 85% sensitivity and 42% specificity.
Conclusion:
The CHA2DS2-VASc score is an independent predictor of the development of CIN in patients with PAD undergoing endovascular intervention.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management